Hélène Chacun Selected Research

miltefosine (Impavido)

2/2006

Modulation of intestinal barrier properties by miltefosine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hélène Chacun Research Topics

Disease

5	Neoplasms (Cancer) 10/2017 - 12/2002
3	Spinal Cord Injuries (Spinal Cord Injury) 08/2015 - 01/2014
2	Hyperthermia 10/2017 - 05/2015
2	Stroke (Strokes) 01/2015 - 01/2014
1	Atherosclerosis 09/2018
1	Brain Ischemia (Cerebral Ischemia) 08/2015
1	Rupture 11/2014
1	Neurologic Manifestations (Neurological Manifestations) 01/2014
1	HIV Infections (HIV Infection) 12/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Choriocarcinoma 03/2009
1	Breast Neoplasms (Breast Cancer) 03/2009
1	Visceral Leishmaniasis (Kala Azar) 02/2006
1	Brain Neoplasms (Brain Tumor) 12/2002
1	Gliosarcoma 12/2002

Drug/Important Bio-Agent (IBA)

3	Adenosine (Adenocard)FDA LinkGeneric 08/2015 - 01/2014
2	NanocapsulesIBA 10/2017 - 11/2016
2	Liposomes (Liposome)IBA 05/2015 - 12/2002
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2018
1	poly(lactide) (polylactic acid)IBA 09/2018
1	ThiazolidinedionesIBA 09/2018
1	Rosiglitazone (Avandia)FDA Link 09/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2017
1	EmulsionsIBA 11/2016
1	nasIBA 08/2015
1	Fluorouracil (Carac)FDA LinkGeneric 05/2015
1	Adenosine Triphosphate (ATP)IBA 11/2014
1	LipidsIBA 01/2014
1	NucleosidesIBA 01/2014
1	SqualeneIBA 01/2014
1	zidovudine triphosphateIBA 12/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 03/2009
1	Riluzole FDA LinkGeneric 03/2009
1	Busulfan (Busulfex)FDA Link 11/2006
1	Alkylating AgentsIBA 11/2006
1	miltefosine (Impavido)IBA 02/2006
1	Ethylene Glycol (Monoethylene Glycol)IBA 12/2002

Therapy/Procedure

1	Intravenous Injections 12/2002
1	Nanospheres 12/2002